Masja De Haas (M de Haas, Masja de Haas)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 18

Top Topics

Randomized Controlled Trial

Top Venues

Journal of thrombosis and haemostasis : JTH

BJOG : an international journal of obstetrics and gynaecology

This page only lists publications with an associated author ORCID identifier.

Publications

Merel L Wemelsfelder, Ronald H G van de Weem, Jessie S Luken, Masja De Haas, René W L M Niessen, C Ellen Van Der Schoot, Han Hoogeveen, Folarin B Oyebolu, Dick den Hertog, Mart P Janssen
Extensive red blood cell matching considering patient alloimmunization risk. Vox sanguinis 119 (4) (2024)
Romy T Meier, Leendert Porcelijn, Suzanne Hofstede-van Egmond, Yvonne M C Henskens, Jonathan M Coutinho, Marieke J H A Kruip, An K Stroobants, Jaap J Zwaginga, Johanna G van der Bom, C Ellen Van Der Schoot, Masja De Haas, Rick Kapur
Laboratory approach for vaccine-induced thrombotic thrombocytopenia diagnosis in the Netherlands. Vox sanguinis 119 (7) (2024)
Carolien Zwiers, Yolentha Maria Slootweg, Joke M Koelewijn, Peter C Ligthart, Johanna van der Bom, Inge L van Kamp, Enrico Lopriore, C Ellen Van Der Schoot, Dick Oepkes, Masja De Haas
Disease severity in subsequent pregnancies with RhD immunization: A nationwide cohort. Vox sanguinis (2024)
Romy T Meier, Leendert Porcelijn, Suzanne Hofstede-van Egmond, Yvonne M C Henskens, Jonathan M Coutinho, Marieke J H A Kruip, An K Stroobants, Jaap J Zwaginga, Johanna G van der Bom, C Ellen Van Der Schoot, Masja De Haas, Rick Kapur
Laboratory approach for vaccine-induced thrombotic thrombocytopenia diagnosis in the Netherlands. Vox sanguinis (2024)
Merel L Wemelsfelder, Ronald H G van de Weem, Jessie S Luken, Masja De Haas, René W L M Niessen, C Ellen Van Der Schoot, Han Hoogeveen, Folarin B Oyebolu, Dick den Hertog, Mart P Janssen
Extensive red blood cell matching considering patient alloimmunization risk. Vox sanguinis (2024)
Jessie S Luken, Claudia C Folman, Johan H Meekers, Michael V Lukens, C Ellen Van Der Schoot, Masja De Haas
Major reduction in occurrence of anti-c and anti-E in pregnancy after more than 10 years of preventive matched transfusion with most benefit for c-matching. British journal of haematology (2024)
Carolien Zwiers, Yolentha Maria Slootweg, Joke M Koelewijn, Peter C Ligthart, Johanna van der Bom, Inge L van Kamp, Enrico Lopriore, C Ellen Van Der Schoot, Dick Oepkes, Masja De Haas
Disease severity in subsequent pregnancies with RhD immunization: A nationwide cohort. Vox sanguinis 119 (8) (2024)
Merel L Wemelsfelder, Ronald H G van de Weem, Jessie S Luken, Masja De Haas, René W L M Niessen, C Ellen Van Der Schoot, Han Hoogeveen, Folarin B Oyebolu, Dick den Hertog, Mart P Janssen
Extensive red blood cell matching considering patient alloimmunization risk. Vox sanguinis 119 (4) (2024)
Romy T Meier, Leendert Porcelijn, Suzanne Hofstede-van Egmond, Yvonne M C Henskens, Jonathan M Coutinho, Marieke J H A Kruip, An K Stroobants, Jaap J Zwaginga, Johanna G van der Bom, C Ellen Van Der Schoot, Masja De Haas, Rick Kapur
Laboratory approach for vaccine-induced thrombotic thrombocytopenia diagnosis in the Netherlands. Vox sanguinis 119 (7) (2024)
Marjon H Cnossen, Iris van Moort, Simone H Reitsma, Moniek P M de Maat, Roger E G Schutgens, Rolf T Urbanus, Hester Floor Lingsma, Ron A A Mathot, Samantha C Gouw, Karina Meijer, Annelien L Bredenoord, Rieke van der Graaf, Karin C J Fijnvandraat, Alexander Benjamin Meijer, Emile van den Akker, Ruben Bierings, Jeroen C J Eikenboom, Maartje van den Biggelaar, Masja De Haas, Jan Voorberg, Frank W G Leebeek, null null
SYMPHONY consortium: Orchestrating personalized treatment for patients with bleeding disorders. Journal of thrombosis and haemostasis : JTH (2022)
Yolentha Maria Slootweg, Carolien Zwiers, Johanna Maria Koelewijn, C Ellen Van Der Schoot, D Oepkes, Inge L Van Kamp, Masja De Haas
Risk factors for RhD immunisation in a high coverage prevention programme of antenatal and postnatal RhIg: a nationwide cohort study. BJOG : an international journal of obstetrics and gynaecology 129 (10) (2022)
Jessie S Luken, Sebastien P Ritsema, Merel M Van der Wal, C Ellen Van Der Schoot, Etiënne A J A Rouwette, Masja De Haas, Mart P Janssen
Mapping anticipated advantages and disadvantages of implementation of extensive donor genotyping: A focus group approach. Transfusion medicine (Oxford, England) 32 (5) (2022)
Elise J Huisman, A Rick Brooimans, Samone Mayer, Marieke Joosten, Louis J Bont, Mariëlle Dekker, Elisabeth L M Rammeloo, Frans J Smiers, P Martin van Hagen, Christian Michel Zwaan, Masja De Haas, Marjon H Cnossen, Virgil A S H Dalm
Patients with Chromosome 11q Deletions Are Characterized by Inborn Errors of Immunity Involving both B and T Lymphocytes. Journal of clinical immunology 42 (7) (2022)
Derek P De Winter, Christian V Hulzebos, Renske M van 't Oever, Masja De Haas, E J T Joanne Verweij, Enrico Lopriore
History and current standard of postnatal management in hemolytic disease of the fetus and newborn. European journal of pediatrics (2022)
Thijs L J van Osch, Tamas Pongracz, Dionne M Geerdes, Juk Yee Mok, Wim J E van Esch, Jan Voorberg, Rick Kapur, Leendert Porcelijn, Jean-Louis H Kerkhoffs, Pieter F van der Meer, C Ellen Van Der Schoot, Masja De Haas, Dana L E Vergoossen, Gestur Vidarsson
Altered Fc glycosylation of anti-HLA alloantibodies in hemato-oncological patients receiving platelet transfusions. Journal of thrombosis and haemostasis : JTH 20 (12) (2022)
Jessie S Luken, Claudia C Folman, Michaël V Lukens, Johan H Meekers, Peter C Ligthart, Henk Schonewille, Jaap Jan Zwaginga, Mart P Janssen, C Ellen Van Der Schoot, Johanna van der Bom, Masja De Haas
Reduction of anti-K-mediated hemolytic disease of newborns after the introduction of a matched transfusion policy: A nation-wide policy change evaluation study in the Netherlands. Transfusion 61 (3) (2021)
Ronald H G van de Weem, Merel L Wemelsfelder, Jessie S Luken, Masja De Haas, René W L M Niessen, C Ellen Van Der Schoot, Han Hoogeveen, Mart P Janssen
Preventing alloimmunization using a new model for matching extensively typed red blood cells. Vox sanguinis (2021)
Dian Winkelhorst, Thijs W de Vos, Marije M Kamphuis, Leendert Porcelijn, Enrico Lopriore, Dick Oepkes, C Ellen van der Schoot, Masja De Haas
HIP (HPA-screening in pregnancy) study: protocol of a nationwide, prospective and observational study to assess incidence and natural history of fetal/neonatal alloimmune thrombocytopenia and identifying pregnancies at risk. BMJ open 10 (7) (2020)